Covid-1 hospital admissions could make patients with other dangerous infections worldwide sick: drug-resistant superbugs Candida uris res, National Geographic Report.
Superbug a Yeast Which infects the ears and open wounds, and can even enter the bloodstream to cause serious infections throughout the body, U.S. Department of Disease Control and Prevention According to the centers (CDC). The yeast sticks to the surface and spreads easily in health care settings, especially in patients with catheters or other tubes that enter their body.
Now, the initial data indicates that the rush COVID-19 Patients in hospitals can also increase it C. Eris Cases, according to the National Geographic Report. Notably, 1,272 cases of fungal infections have been reported in the United States this year, According to the CDC – whose number has increased by about 400% Cases have been reported throughout 2018, The most recent year with available information. The number of cases reported in 2020 could be even higher than reported, although the ongoing epidemic has disrupted surveillance systems used to track the spread of the fungus. Other types of fungi in Candida The genus closely resembles C. Eris, So doctors can only identify yeast using a specialized laboratory test.
Related: 20 worst epidemics and pandemics in history
“Unfortunately, there have been places where we have seen a resurrection C. Uris Rees,“Dr. Tom Chiller, head of the mycotic diseases branch at CDC, told National Geographic.” We have also seen him admitted to some intensive care hospitals and some Covid-19 units… the concern is that once he sets up shop in one place, it is difficult to get rid of. “
According to the CDC, “patients can remain colonized C. Eris As long as, the fungus can stay on them Skin Without the necessary features, “and C. Eris Healthcare can remain constant on the surface in the environment. “Superbugs can also be notoriously difficult to treat. C. Eris Yeast comes in several types that show different classes of resistance Antibiotics; In particular, show resistance to common antifungal fluconazole has been studied in many variants, and many show resistance to amphoteric toricin B, a second-line antifungal drug that can be given if the initial antibiotic fails. Because of drug-resistance, doctors sometimes have to treat patients with third-line drugs if the second-line treatment also fails.
The most well-known types C. Eris The CDC notes that third-line antifungals, known as echinoc and nandins, can be treated, but these treatments are not readily available in all countries and some types of yeast show resistance to all three classes of antifungals, the CDC notes. Since yeast was first identified in 2009, several thousand cases have been reported worldwide; At the same time, about 30% to 60% of people worldwide die from fungal infections, according to the agency, although many of these people had other serious illnesses at once.
Dr Anuradha Chaudhary, a professor of medical mycology at the Vallabhbhai Patel Chest Institute at Delhi University, told National Geographic that Kovid-19 patients should be screened regularly. C. Eris, To accurately track infection rates and identify which antibiotic treatment, if any, can help recover affected patients.
“If we don’t know it, then we don’t know if a patient is dying of covid-19 or another infection,” Chaudhary said. But “if it’s resistant to drugs, how do we treat it?” He added.
If a given variable C. Eris Resists all three classes of antifungal drugs, “Multiple classes of antifungals may be required at high doses to treat the infection,” but this treatment will be the last resort, the CDC notes. Research suggests that using several classes of antifungals at the same time may have an additive effect and help strengthen yeast resistance to individual drugs, although this needs to be confirmed with more data.
You can learn more about C. Eris On National Geographic.
Published on Original Living Science.
